+
Site Tour

R. Dworakowski "It's an ideal valve to be used for patients who may require future coronary interventions"

Discover what M. Van Wely, W-K. Kim, S. Khogali, M. Ozkor and R. Dworakowski think about Navitor™ and future interventions

Related Videos

Now you've got Navitor. Remarkable performance.

Now you've got Navitor.
Stable delivery.

TAVI 2023: Younger patients

Cruz's testimonial

PremiClose 2024: Pediatric cardiologist view

Javier's testimonial

TAVI Summit 2023: AS with HF

EuroPCR 2023: Defining the future

Navitor™: Voice of the Experts Federico de Marco

ESC 2023 Tutorial – TriClip™ | Dr. Coisne

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

Epic Mitral – 10-Year Clinical Outcomes

ESC 2021: HF & VHD Guidelines

bRIGHT study

Amplatzer™ Valvular Plug III – Patients

CONNEXT


LIVE
RELATED EVENTS

EuroPCR 2023: Defining the future

PremiClose 2024: Medical therapy or wait

TAVI Summit - What is coming next

TAVI Summit 2023: Streamline implantation

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline